CoChat

Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections

Open access

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.

Abstract

Background: We conducted a prospective cohort study in Zambia among pregnant women who received intermittent preventive treatment using sulfadoxine-pyrimethamine (IPTp-SP). Methods: We calculated the odds ratios (ORs) of adverse birth outcomes by IPTp-SP exposure, 0-1 dose (n = 126) vs ≥2 doses (n = 590) and ≥2 doses (n = 310) vs ≥3 doses (n = 280) in 7 categories of malaria infection and sexually transmitted and reproductive tract infections (STIs/RTIs). Results: We found no significant differences in baseline prevalence of infection across IPTp-SP exposure groups. However, among women given 2 doses compared to 0-1 dose, the odds of any adverse birth outcome were reduced 45% (OR, 0.55; 95% confidence interval [CI], 0.36, 0.86) and 13% further with ≥3 doses (OR, 0.43; 95% CI, 0.27, 0.68). Two or more doses compared to 0-1 dose reduced preterm delivery by 58% (OR, 0.42; 95% CI, 0.27, 0.67) and 21% further with ≥3 doses (OR, 0.21; 95% CI, 0.13, 0.35). Women with malaria at enrollment who received ≥2 doses vs 0-1 had 76% lower odds of any adverse birth outcome (OR, 0.24; 95% 0.09, 0.66), and Neisseria gonorrhoeae and/or Chlamydia trachomatis had 92% lower odds of any adverse birth outcome (OR, 0.08; 95% CI, 0.01, 0.64). Women with neither a malaria infection nor STIs/RTIs who received ≥2 doses had 73% fewer adverse birth outcomes (OR, 0.27; 95% CI, 0.11, 0.68). Conclusions: IPTp-SP appears to protect against malaria, STIs/RTIs, and other unspecified causes of adverse birth outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cix026

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 6

  1. World Health Organization, 2013, WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)
  2. World Health Organization, 2010, Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach
  3. 1999, Chapter 14: Dealing with confounding in the analysis, 305
  4. World Health Organization, 2006, Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults. Recommendations for a public health approach
  5. 1998, Sulfonamide antibiotics, 4
  6. 1991, The Risks and Severity of Malaria in Pregnant Women. Applied Field Research in Malaria Reports. Geneva, Switzerland: Special Programme for Research and Training in Tropical Diseases

Cited by

See all 77

Metadata

Authors
Chico, R. M., Chaponda, E. B., Ariti, C., & Chandramohan, D.
Affiliations
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Zambia (ZM)
Corresponding author
Chico, R. Matthew
Venue
Clinical Infectious Diseases
Published
2017-03-02
Volume
64
Issue
8
Pages
1043-1051
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2593167305
Cited by
68
References
35
Citations by year
2026: 6 · 2025: 12 · 2024: 8 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 10 · 2019: 11 · 2018: 5 · 2017: 1
FWCI
6.92
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Clinical Infectious Diseases (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
sulfadoxine-pyrimethamine, intermittent preventive treatment in pregnancy, IPTp-SP, dose-response relationship, adverse birth outcomes, malaria in pregnancy, sexually transmitted infections, reproductive tract infections, preterm birth, Neisseria gonorrhoeae, Chlamydia trachomatis, pregnant women, Zambia, maternal and child health
MeSH terms
Adult, Anti-Infective Agents, Drug Combinations, Female, Humans, Malaria, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Prospective Studies, Pyrimethamine, Sexually Transmitted Diseases, Sulfadoxine, Zambia, Treatment Outcome, Chemoprevention, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections. https://app.cochat.ai/papers/10.1093/cid/cix026
The paper
Chico, R. M., Chaponda, E. B., Ariti, C., & Chandramohan, D. (2017). Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cix026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.